Replies to post #7874 on Rebus Holdings Inc (RBSH)

[flaflyersfan]

Goodmooring, maybe because in 22 days NSPX will be 2 Annual reports delinquent and the last filing way back in 2017 showed NSPX had $18,000 in cash, $8.6 million in liabilities, and $2.48 million in convertible debt that the company's current share structure could not cover.

Nothing matters unless NSPX starts filing with the SEC again. A publicly traded company should put out a Press Release if they plan on doing so, not just tell people who call and email them that they plan to.

Good luck.

[Goodmooring]

"Perhaps one of the most important studies"

This is how Mipsagargin is being PUBLISHED in 2019!!!

https://www.mdpi.com/2072-6694/11/2/145/htm

Article Received: 21 December 2018 / Accepted: 23 January 2019 / Published: 26 January 2019


"Perhaps one of the most important studies, is recent completion of phase II clinical trial of Mipsagargin (also known as G-202) for recurrent or progressive glioblastoma (NCT02067156), as well as for prostate cancer [87]. Mipsagargin which is a SERCA pump inhibitor, is an analogue of thapsigargin. Mipsagargin is a non-toxic prodrug that is activated through binding to and cleavage by prostate-specific membrane antigen (PSMA) that is rich in many cancers"

$NSPX keeps getting STRONGER...